| Dr Miriam Yvette Atkins, MD | |
|
3696 Wheeler Rd, Augusta, GA 30909-6520 | |
| (706) 736-1830 | |
| (706) 737-5103 |
| Full Name | Dr Miriam Yvette Atkins |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 33 Years |
| Location | 3696 Wheeler Rd, Augusta, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649257890 | NPI | - | NPPES |
| 00884111B | Medicaid | GA | |
| 2379532 | Other | GA | AETNA |
| 825427 | Other | GA | BLUE CROSS BLUE SHIELD |
| 3600081 | Other | GA | UNITED HEALTHCARE |
| 83BBBQH | Other | GA | MEDICARE ID |
| 830007147 | Other | GA | RAILROAD MEDICARE |
| G48591 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 48591 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Hospital | Augusta, GA | Hospital |
| Doctors Hospital | Augusta, GA | Hospital |
| Aiken Regional Medical Center | Aiken, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Augusta Oncology Associates, P.c. | 8921089756 | 27 |
| Augusta Oncology Associates, P.c. | 8921089756 | 27 |
News Archive
Monkey brain scans have revealed new information about the part of the brain that processes visual information.
It's well known that a relatively small percentage of chronically ill patients account for a disproportionate amount of health care dollars. Now, a multicenter study led by Johns Hopkins researcher Bruce Leff, M.D., might provide insights into how to cut Medicare costs while improving health care for older adults suffering from chronic health conditions.
ViiV Healthcare today announced the start of a Phase III clinical trial programme to evaluate the safety and efficacy of dolutegravir (Tivicay) and rilpivirine (Edurant) as maintenance therapy for adult patients with HIV.
IRIN reports on the issue of sexual violence against men as a "weapon of war" in the Democratic Republic of the Congo (DRC), writing, "Sexual violence against men, including rape, is under-reported, poorly addressed and has a severe impact on both men and their families, according to a presentation at the annual Sexual Violence and Research Initiative (SVRI), held in Cape Town, South Africa."
Caris Life Sciences, a leading biotechnology company focused on fulfilling the promise of precision medicine, today announced the results of a study identifying the clinical benefit of targeted therapy in colorectal cancer (CRC) with high microsatellite instability (MSI-H), a predisposition that occurs in 15% of all CRCs causing significantly different prognosis and response to treatment.
› Verified 3 days ago
| Entity Name | Augusta Oncology Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912917824 PECOS PAC ID: 8921089756 Enrollment ID: O20040527000702 |
News Archive
Monkey brain scans have revealed new information about the part of the brain that processes visual information.
It's well known that a relatively small percentage of chronically ill patients account for a disproportionate amount of health care dollars. Now, a multicenter study led by Johns Hopkins researcher Bruce Leff, M.D., might provide insights into how to cut Medicare costs while improving health care for older adults suffering from chronic health conditions.
ViiV Healthcare today announced the start of a Phase III clinical trial programme to evaluate the safety and efficacy of dolutegravir (Tivicay) and rilpivirine (Edurant) as maintenance therapy for adult patients with HIV.
IRIN reports on the issue of sexual violence against men as a "weapon of war" in the Democratic Republic of the Congo (DRC), writing, "Sexual violence against men, including rape, is under-reported, poorly addressed and has a severe impact on both men and their families, according to a presentation at the annual Sexual Violence and Research Initiative (SVRI), held in Cape Town, South Africa."
Caris Life Sciences, a leading biotechnology company focused on fulfilling the promise of precision medicine, today announced the results of a study identifying the clinical benefit of targeted therapy in colorectal cancer (CRC) with high microsatellite instability (MSI-H), a predisposition that occurs in 15% of all CRCs causing significantly different prognosis and response to treatment.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Miriam Yvette Atkins, MD 3696 Wheeler Rd, Augusta, GA 30909-6520 Ph: (706) 736-1830 | Dr Miriam Yvette Atkins, MD 3696 Wheeler Rd, Augusta, GA 30909-6520 Ph: (706) 736-1830 |
News Archive
Monkey brain scans have revealed new information about the part of the brain that processes visual information.
It's well known that a relatively small percentage of chronically ill patients account for a disproportionate amount of health care dollars. Now, a multicenter study led by Johns Hopkins researcher Bruce Leff, M.D., might provide insights into how to cut Medicare costs while improving health care for older adults suffering from chronic health conditions.
ViiV Healthcare today announced the start of a Phase III clinical trial programme to evaluate the safety and efficacy of dolutegravir (Tivicay) and rilpivirine (Edurant) as maintenance therapy for adult patients with HIV.
IRIN reports on the issue of sexual violence against men as a "weapon of war" in the Democratic Republic of the Congo (DRC), writing, "Sexual violence against men, including rape, is under-reported, poorly addressed and has a severe impact on both men and their families, according to a presentation at the annual Sexual Violence and Research Initiative (SVRI), held in Cape Town, South Africa."
Caris Life Sciences, a leading biotechnology company focused on fulfilling the promise of precision medicine, today announced the results of a study identifying the clinical benefit of targeted therapy in colorectal cancer (CRC) with high microsatellite instability (MSI-H), a predisposition that occurs in 15% of all CRCs causing significantly different prognosis and response to treatment.
› Verified 3 days ago
Dr. Bryan Richard Broach, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-8623 | |
Dr. Kayla Ashley Shahbazian, DO Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-8623 Fax: 706-721-1459 | |
Dr. Harvey Schwartz, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-2273 | |
Dr. Anam Asif Herekar, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-2423 | |
Dr. Robert Allen Price, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1701 Magnolia Way Ste 101, Augusta, GA 30909 Phone: 706-922-6600 Fax: 706-650-0239 | |
Matthew Kevin Howard, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 818 Saint Sebastian Way, Suite 311, Augusta, GA 30901 Phone: 706-724-3473 | |
Enoch Busulwa Lule, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1350 Walton Way, Augusta, GA 30901 Phone: 706-774-5542 Fax: 706-774-5789 |